{"name":"Fulcrum Therapeutics","slug":"fulcrum-therapeutics","ticker":"FULC","exchange":"NASDAQ","domain":"fulcrumtx.com","description":"","hq":"Cambridge, MA","founded":0,"employees":"","ceo":"","sector":"Rare Disease / Neuromuscular","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":8000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-04-01","type":"pipeline","source":"simplywall.st","summary":"Fulcrum Therapeutics (NASDAQ:FULC) Is In A Good Position To Deliver On Growth Plans - simplywall.st","headline":"Fulcrum Therapeutics (NASDAQ:FULC) Is In A Good Position To Deliver On Growth Plans","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNSGtMS2pJT3VRelY3Qm9MM0o3WmNRdVhMNnppalpuQm12bmRmX2tjajlBNHNGbHNXcTdFZ1NNLW1xWXExQ0w1UkRSYjZkSTdwNS10Y2xqNmVhNkMxbGEwdnAxN2RYYi1pVjJ6WUFPa2FGZkw1X0M1dDVIZEZJcFFFdmpUbm1YSHNMLVllaFF5V1kzU2o0V0xLZTZNb1NrYk9B?oc=5","date":"2026-03-31","type":"regulatory","source":"Investor's Business Daily","summary":"The Surprise FDA Move That Sent Two Biotechs Rallying - Investor's Business Daily","headline":"The Surprise FDA Move That Sent Two Biotechs Rallying - Investor's Business Daily","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxNa2c5RWVob0UwcGplR2dISkJpNldIUlJNdDRxRVU3aWdFNU4wcFVXcGd0SUVGa2QxdGJfdzNkbmp1Nlk5aVNZWlBWZE9MalY5UXhiaHFFTHljblpNMGdSejd5SUhSaFNTYjRqSVVaems0S3N6TU5jZ0pFWjFrcHBJbE5RbGtDUzBnaEZGeWN5Z1Q5MFlXRkNacDMwUV9tTVNPUnM3a21SRlFsajJaUVp6OFhwMWFrRWdWTFZDQlR2U2E4V01XLVhZVnZhd2tmeUp6QWZjdkh2azZodk9EdktCR1VVUWJFa0hLSU1OVG1TdWJxZHBaTWhNN2o1VF8yYjBCV2VuQWpXOGQ?oc=5","date":"2026-03-31","type":"pipeline","source":"Benzinga","summary":"Apellis Pharmaceuticals, Centessa Pharmaceuticals, Agios Pharmaceuticals And Other Big Stocks Moving High - Benzinga","headline":"Apellis Pharmaceuticals, Centessa Pharmaceuticals, Agios Pharmaceuticals And Other Big Stocks Moving High","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxQLXF0NkpCRzNNU0xYZnhkdUNsbk9Kc3VqajhKZkFuLS01cy14cXd0WTdRU082Zi1UU2FnOWVUNmZ5WlBzMzRGWTlEbGNvS0Z4LV9TdGlnQUVic1pyNFNIMFQ3TXpVUGJUd3ZGZnZSWjZxbWZ0NHdnTFE2ODh0UGx3V2k1WnByRkV1ZzdEU3VaZzcxSDRDNjFFM29VT3UyQlhrMVNKRTdTNmtpMkF4YkJaak93TDJHMkZuZ19nVVZxYkluUU1BOE0wejdGX3BIbkJZdDR6ZUdEX04zUQ?oc=5","date":"2026-03-22","type":"pipeline","source":"marketscreener.com","summary":"Fulcrum Therapeutics, Inc.(NasdaqGM:FULC) added to S&P Pharmaceuticals Select Industry Index - marketscreener.com","headline":"Fulcrum Therapeutics, Inc.(NasdaqGM:FULC) added to S&P Pharmaceuticals Select Industry Index","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8AFBVV95cUxNQk5QWkw2eDh5WGdCdHdEN0dPQUVKSUZuUlh6QkdjVGlUa2VYSEQ2VzgwOTFvOHM2UDUtOU1ZM09COFJqM0JYZnZaQ21zRFg5djh6T09BWGs1bk5rejNEcTVsSlU2Yi1wWmE1aFE0RGdTTGlHSE85TjBxWkFoVGdtRGxjekt4N3hVNHhrY2RxbjN6bGt5RE5YQ3hYUGlSbWpwVlhGVUFrWnFFazNzTnZtUGNXaElRXzI3Y29JbWxJdThfMnpTWG9LTlU1TEhMLTFtRlNDQjNLTWxqdGd1a2R4cERtNnlEcGtsWGVfSlNMUzA?oc=5","date":"2026-01-07","type":"pipeline","source":"GlobeNewswire","summary":"Fulcrum Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewswire","headline":"Fulcrum Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-09","type":"trial","source":"simplywall.st","summary":"Fulcrum Therapeutics (FULC): Valuation Check After PIONEER Trial Success and Follow-On Offering - simplywall.st","headline":"Fulcrum Therapeutics (FULC): Valuation Check After PIONEER Trial Success and Follow-On Offering","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxOVzhQV1NVTnJTN015bDZaNXlZQVBlZVhoMGo3YnJJbzJoa0NPQS1sZzgwOWhNOHVlS2JQdnpzY1pBendzYUVsb0N1UF9MNkZkRVR2N1FKODRTU1hKWDBHTGJzcWpfVlFjSTZvNHFQZGt4SFV0dFdCTHViOGlQTERuOERmTVV4ZllVWGdSXzBHME16XzJ6NnhYeGwydmpQR0FfYTNn?oc=5","date":"2025-11-19","type":"pipeline","source":"Investor's Business Daily","summary":"This Biotech Just Lost Half Its Value As Its Rival Celebrated - Investor's Business Daily","headline":"This Biotech Just Lost Half Its Value As Its Rival Celebrated - Investor's Business Daily","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxQUnBGdllZNWNyQ1RfTmw2THF2Q2dsekk1Rktpa25tNUpkd2lyalI4NWp6X0tFQndMNW4weW54dU53cXpoNjZWdW1XTGxBMElyR1Bhelh0ZUoyeGtiRE1QMTNJLU9YeTF6VHlRLUtrckNOZnZjZEZUVVE3TnBORXItOFBMTDRid3dj?oc=5","date":"2024-09-13","type":"pipeline","source":"The Pharma Letter","summary":"Fulcrum failure sends shares 61% downwards - The Pharma Letter","headline":"Fulcrum failure sends shares 61% downwards","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPcEUzQm9KUFVlU2F3eWNsOVFUVFhzaHdGVDBrMTZuUEhUVHc0RWtPalVSUklxdTdDVElUaDE4NklFRXNvWUFnbmRsV1VLYWI1MTlMTkFSVTlpSDFQaFJvOWEzc3p1QjhSZmIwUTl6SklOdGxGdjczZmo0RXNxUjNpMDFMMFFJSTNSeDdwaVdTX1lSbHdIaWo4NFlB?oc=5","date":"2024-09-12","type":"deal","source":"BioPharma Dive","summary":"Fulcrum shares collapse as Sanofi-partnered muscular dystrophy drug fails key test - BioPharma Dive","headline":"Fulcrum shares collapse as Sanofi-partnered muscular dystrophy drug fails key test","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxQU0U4N2VySGNYM0lJRDlTX19aNFBLeW1ib1JCZ3NJZjJBNlpJUEJoWUU3a3Y1SFZTUGI4Qkd0M0stOGhqTW1IOFNmdk5sbVZVZ1ZYSTBueVFtRFVEVVZTWVUzYjJWbmhlcFY2WDlwemJ4eFdaMzFxRE5tQTVrR01aOFpFWnlyel9Vc29kZzJrcWdpUkpTUkIyVGdndnhSLTZHS2pvM2EzUEhVS3gtR24yOUM1cw?oc=5","date":"2024-09-12","type":"trial","source":"Fierce Biotech","summary":"Sanofi's $80M bet on Fulcrum's dystrophy drug ends in phase 3 failure after 4 months - Fierce Biotech","headline":"Sanofi's $80M bet on Fulcrum's dystrophy drug ends in phase 3 failure after 4 months","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxPdWE3SHlPSGxYR0JFdDY0di1lUGtJekU0U2hHMDAzRDN1VGhuTS1XWkRpZXlzcGcyZWFLN0dsUjV6UGdEREJRdGYzRnJnWGxwbzU2cTRCakVsbExJdjN2MUptd1o2MmZ2VjJOaW5fY0E2WV95aFNzcFQ3ZnlMdnJ3czhTNWZIUkNsQXhKdkkxUWJMV3JtdjdUdEVPMGliUUt0S1dVbGN5SGhnWmxGSlpfd293?oc=5","date":"2024-05-13","type":"deal","source":"Pharmaceutical Technology","summary":"Sanofi strikes $1bn deal with Fulcrum for muscular dystrophy drug - Pharmaceutical Technology","headline":"Sanofi strikes $1bn deal with Fulcrum for muscular dystrophy drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxPODlzdHdfRlVlZW9tVDNDYVIyZkpDRmlyRXh2dUtwSUpxYlhyMzM0QTJvTEF5ZjEtcl9ZNkxWRThFTWI1REpHaWtoMGNzRUhSN29lX1pxMkxEU0R5TV9lSVdlY1JFRnhyNFMwTGdMS09xb01vNzBWLU9pb3ZZaVZ6a2Q2RkpnRXFfWUhwdm1WckE3X2liZmVHX2VlWGpWemt0Z2I2NFhibw?oc=5","date":"2024-05-13","type":"deal","source":"Contract Pharma","summary":"Fulcrum Enters Collaboration & License Agreement with Sanofi - Contract Pharma","headline":"Fulcrum Enters Collaboration & License Agreement with Sanofi","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}